The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma

Published:2017-02-02 Issue:9 Volume:8 Page:15846-15857
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Geier Andreas¹,Macias Rocio I.R.²,Bettinger Dominik³,Weiss Johannes¹,Bantel Heike⁴,Jahn Daniel¹,Al-Abdulla Ruba²,Marin Jose J.G.²

Affiliation:

1. Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg, Germany

2. Experimental Hepatology and Drug Targeting, CIBERehd, IBSAL, University of Salamanca, Salamanca, Spain

3. Department of Medicine II, University Hospital Freiburg, Freiburg, Germany

4. Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy;Cancer Drug Resistance;2024-07-18

2. Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma;International Journal of Molecular Sciences;2024-02-12

3. Potential of African plants and their derived phytochemicals against hepatocellular carcinoma;Advances in Botanical Research;2024

4. Role of organic cation transporter 3 (OCT3) in the response of hepatocellular carcinoma to tyrosine kinase inhibitors;Biochemical Pharmacology;2023-11

5. Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma;Translational Gastroenterology and Hepatology;2023-10